Mahkam Zanganeh's Net Worth

$336 Million

Estimate Recalculated Feb 14, 2024 04:40PM EST

Who is Mahkam Zanganeh?

Mahkam Zanganeh has an estimated net worth of $336 Million. This is based on reported shares across multiple companies, which include Summit Therapeutics Inc., Pulse Biosciences, Inc., and PHARMACYCLICS INC.

SEC CIK

Mahkam Zanganeh's CIK is 0001507650

Past Insider Trading and Trends

2017 was Mahkam Zanganeh's most active year for acquiring shares with 21 total transactions. Mahkam Zanganeh's most active month to acquire stocks was the month of April. 2015 was Mahkam Zanganeh's most active year for disposing of shares, totalling 23 transactions. Mahkam Zanganeh's most active month to dispose stocks was the month of April. 2023 saw Mahkam Zanganeh paying a total of $51,139,389.84 for 60,142,360 shares, this is the most they've acquired in one year. In 2015 Mahkam Zanganeh cashed out on 1,359,507 shares for a total of $131,164,952.95, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Summit Therapeutics Inc. (SMMT) Snapshot price: $4.23

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.30%
810.5K
$1.52
$1,214,458.14
25.38M
Dec 11 - Dec 12
Form 4
0
0
Oct 13
Form 4/A
+215.24%
23.53M
$1.05
$24,703,396.20
34.46M
Mar 8
Form 4
+215.24%
23.53M
$1.05
$24,703,396.20
34.46M
Mar 8
Form 4
+3.54%
373.86K
10.93M
Dec 6
Form 4
+122.35%
5.81M
$0.97
$5,634,858.04
10.56M
Aug 16
Form 4
0
0
Dec 15
Form 4
+17.26%
389.08K
$5.24
$2,038,763.48
2.64M
May 12
Form 4
0
0
Nov 22
Form 4
0
0
Nov 11
Form 3
0
0
No matching records found

Pulse Biosciences, Inc. (PLSE) Snapshot price: $8.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+14.39%
76.08K
$2.14
$162,800.50
604.91K
Nov 13
Form 4/A
+19.60%
86.67K
$2.05
$177,669.40
528.84K
Jun 9
Form 4
+12.29%
86.67K
$2.05
$177,669.40
791.91K
Jun 9
Form 4
0
0
May 25
Form 4
+24.38%
86.67K
442.17K
Jun 9
Form 4
0
0
May 19
Form 4
0
0
May 20
Form 4
+0.72%
3.31K
$7.01
$23,182.07
462.57K
Jan 8 - Jan 19
Form 4
+1.13%
1.19K
$10.70
$12,767.13
106.77K
Jun 23
Form 4
+8.14%
7.95K
$7.01
$55,729.50
105.57K
Jun 17
Form 4
+5.15%
22.05K
$7.01
$154,570.50
450.12K
Jun 15
Form 4
0
0
May 18
Form 4
0
0
May 16
Form 4
0
0
Jan 7
Form 4
0
0
May 23
Form 3/A
0
0
Form 4
+1.16%
1.1K
$23.98
$26,378.00
95.57K
Dec 13
Form 4
+4.42%
4K
$23.07
$92,268.00
94.47K
Dec 11 - Dec 12
Form 4
0
0
Nov 2
Form 4
+9.84%
29.77K
$13.36
$397,669.91
332.5K
Sep 14 - Sep 18
Form 4
+7.90%
28.79K
$23.58
$689,800.63
393.2K
Aug 2 - Aug 3
Form 4
0
0
May 16
Form 4
+17.31%
53.76K
$20.60
$1,101,585.32
364.41K
May 9 - May 11
Form 4
+6.24%
18.24K
$23.07
$425,669.28
310.65K
Mar 17 - Mar 20
Form 4
+63.50%
13K
$11.97
$155,649.00
33.47K
Feb 15
Form 4
0
0
Feb 9
Form 3
0
0
No matching records found

PHARMACYCLICS INC No price found

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-443.28K
$261.25
-$115,807,161.25
0
May 26
Form 4/A
+62.46%
140.72K
$128.22
-$7,227,465.30
366.03K
Mar 11 - Mar 12
Form 4
+19.65%
44.28K
$50.61
-$7,449,272.70
366.03K
Mar 11 - Mar 12
Form 4
+7.13%
15K
225.31K
Jan 16
Form 4
0
$68.97
-$4,006,532.06
210.31K
Nov 7 - Nov 12
Form 4
+0.00%
1
$80.93
$80.93
210.31K
Oct 31
Form 4
0
$62.03
-$1,433,380.00
210.31K
Sep 3 - Sep 4
Form 4
+0.10%
204
$80.39
$16,399.56
210.31K
Apr 30
Form 4
0
0
Apr 2
Form 4
-8.69%
-20.00K
$107.55
-$2,151,000.00
210.11K
Dec 16
Form 4
+0.88%
2.01K
$10.56
$21,240.68
230.11K
Apr 30
Form 4
0
0
Oct 26
Form 4
+0.89%
2.01K
$10.56
$21,240.68
228.09K
Apr 30
Form 4
0
0
Dec 1
Form 4
+9.70%
20K
$0.75
$15,000.00
226.08K
Apr 28
Form 4
0
0
Dec 13
Form 3
0
0
No matching records found